再吸収性血管足場市場：材料タイプ、用途、エンドユーザー別-2025-2030年の世界予測

再吸収性血管足場市場は、2023年に5億712万米ドルと評価され、2024年には5億7,657万米ドルに達すると予測され、CAGR 13.78%で成長し、2030年には12億5,252万米ドルに達すると予測されています。

再吸収性血管足場（RVS）は革新的な生体吸収性ステントで、血管に一時的な支持を与えることで冠動脈疾患を治療する心臓インターベンションで主に使用されます。その必要性は、後期ステント血栓症など従来の金属ステントに関連する合併症を減少させる一方で、足場が溶解すると動脈が自然な動きと機能を回復することを可能にする可能性から生じています。用途としては、RVSは血管形成術において極めて重要であり、その最終用途は主に病院、心臓センター、外来手術センターに及んでいます。RVS市場は、心血管障害の有病率の増加、生分解性材料の進歩、低侵襲手術への嗜好の高まりによって牽引されています。しかし、高コスト、厳しい規制要件、金属製ステントと比較した限定的な長期臨床データなど、重大な課題が成長を阻害する可能性があります。ビジネスチャンスは、ヘルスケアのインフラが急速に改善し、高度な医療技術が受け入れられつつある新興市場にあります。医療研究機関との戦略的提携は、特にRVSの有効性と安全性プロファイルの強化において、技術革新を促進する可能性があります。企業は、多様な患者のニーズを満たすために、分解時間の改善と機械的特性の向上を図った足場の開発に注力すべきです。また、個々の解剖学的特殊性や疾患特異性に対応した足場を製造することで、イノベーションをパーソナライゼーションへと導くこともできます。市場関係者は、長期的な安全性と有効性の主張を立証するために包括的な臨床試験に投資し、規制機関とヘルスケアプロバイダーの両方を満足させることが推奨されます。全体として、RVS市場は心臓治療における変革の可能性から有望であるが、現在の制限を克服し、急成長する機会を活用するためには、規制状況、コスト管理、技術強化のナビゲーションにおいて細心の努力が必要です。

市場力学：急速に進化する再吸収性血管足場市場の主要市場インサイトを公開

再吸収性血管足場市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 老年人口におけるCADおよびPADのリスク増大
  • 臨床試験および開発パイプラインの数
  • 心血管疾患の有病率の増加
• 市場抑制要因
  • 代替法の存在
• 市場機会
  • 外科手術の研究開発への資金提供の増加
  • 血管形成術における薬剤溶出デバイスへの傾斜
• 市場の課題
  • 製品リコール

ポーターの5つの力：再吸収性血管足場市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：再吸収性血管足場市場における外部からの影響の把握

外部マクロ環境要因は、再吸収性血管足場市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析再吸収性血管足場市場における競合情勢の把握

再吸収性血管足場市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス再吸収性血管足場市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、再吸収性血管足場市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨再吸収性血管足場市場における成功への道筋を描く

再吸収性血管足場市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者人口におけるCADおよびPADのリスク増加
    • パイプライン内の臨床試験および開発の数
    • 心血管疾患の罹患率の増加
  • 抑制要因
    • 代替手段の存在
  • 機会
    • 外科手術の研究開発への資金提供の増加
    • 血管形成術における薬剤溶出デバイスへの傾向
  • 課題
    • 製品リコール
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 再吸収性血管足場市場素材タイプ別

• 金属ベースのBVS
• ポリマーベースのBVS

第7章 再吸収性血管足場市場：用途別

• 冠動脈ステント
• 末梢動脈ステント

第8章 再吸収性血管足場市場：エンドユーザー別

• 外来手術センター
• 心臓センター
• 病院

第9章 南北アメリカの再吸収性血管足場市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の再吸収性血管足場市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの再吸収性血管足場市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• B. Braun Medical Inc.
• Biotronik SE & Co. KG
• Cardionovum GmbH
• Elixir Medical Corporation
• Kyoto Medical Planning Co., Ltd.
• Lepu Medical Technology（Beijing）Co.,Ltd.
• Medtronic PLC
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• OrbusNeich Medical Company Limited
• Reva Medical, Inc.
• Terumo Corporation
• Translumina
• Wego Healthcare（Shenzhen）Co., Ltd.

LIST OF FIGURES

• FIGURE 1. RESORBABLE VASCULAR SCAFFOLD MARKET RESEARCH PROCESS
• FIGURE 2. RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. RESORBABLE VASCULAR SCAFFOLD MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. RESORBABLE VASCULAR SCAFFOLD MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RESORBABLE VASCULAR SCAFFOLD MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. RESORBABLE VASCULAR SCAFFOLD MARKET DYNAMICS
• TABLE 7. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY METAL BASED BVS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYMER BASED BVS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. POLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. RESORBABLE VASCULAR SCAFFOLD MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. RESORBABLE VASCULAR SCAFFOLD MARKET, FPNV POSITIONING MATRIX, 2023

The Resorbable Vascular Scaffold Market was valued at USD 507.12 million in 2023, expected to reach USD 576.57 million in 2024, and is projected to grow at a CAGR of 13.78%, to USD 1,252.52 million by 2030.

Resorbable vascular scaffolds (RVS) are innovative bioresorbable stents used primarily in cardiac interventions to treat coronary artery disease by providing temporary support to the blood vessel. The necessity arises from their potential to reduce complications associated with traditional metal stents, such as late stent thrombosis, while allowing the artery to restore its natural movement and function once the scaffold dissolves. In terms of application, RVS are pivotal in angioplasty procedures, and their end-use scope primarily spans across hospitals, cardiac centers, and ambulatory surgical centers. The market for RVS is driven by the increasing prevalence of cardiovascular disorders, advancements in biodegradable materials, and a growing preference for minimally invasive procedures. However, significant challenges, including high costs, stringent regulatory requirements, and limited long-term clinical data compared to metallic stents, could inhibit growth. Opportunities lie in emerging markets where healthcare infrastructure is rapidly improving, and there's an increasing acceptance of advanced medical technologies. Strategic collaborations with medical research institutions could expedite innovation, particularly in enhancing the efficacy and safety profiles of RVS. Companies should focus on developing scaffolds with improved degradation timelines and enhanced mechanical properties to meet diverse patient needs. Innovation can also be steered towards personalization, producing scaffolds that cater to individual anatomical peculiarities and disease specifics. Market players are advised to invest in comprehensive clinical trials to substantiate long-term safety and effectiveness claims, thereby satisfying both regulatory bodies and healthcare providers. Overall, the RVS market is promising due to its transformative potential in cardiac care; however, it demands meticulous effort in navigation through regulatory landscapes, cost management, and technological enhancements to surmount current limitations and capitalize on burgeoning opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Resorbable Vascular Scaffold Market

The Resorbable Vascular Scaffold Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing Risk of CAD and PAD in the geriatric population
  • Number of clinical trials and development in pipeline
  • Increasing prevalence of cardiovascular diseases
• Market Restraints
  • Presence of alternative methods
• Market Opportunities
  • Growing funding for R&D of surgical procedures
  • Inclination towards drug-eluting devices for angioplasty
• Market Challenges
  • Product recall

Porter's Five Forces: A Strategic Tool for Navigating the Resorbable Vascular Scaffold Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Resorbable Vascular Scaffold Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Resorbable Vascular Scaffold Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Resorbable Vascular Scaffold Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Resorbable Vascular Scaffold Market

A detailed market share analysis in the Resorbable Vascular Scaffold Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Resorbable Vascular Scaffold Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Resorbable Vascular Scaffold Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Resorbable Vascular Scaffold Market

A strategic analysis of the Resorbable Vascular Scaffold Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Resorbable Vascular Scaffold Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Medical Inc., Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Reva Medical, Inc., Terumo Corporation, Translumina, and Wego Healthcare (Shenzhen) Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Resorbable Vascular Scaffold Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Material Type, market is studied across Metal Based BVS and Polymer Based BVS.
• Based on Application, market is studied across Coronary Artery Stents and Peripheral Artery Stents.
• Based on End User, market is studied across Ambulatory Surgical Centers, Cardiac Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing Risk of CAD and PAD in the geriatric population
    • 5.1.1.2. Number of clinical trials and development in pipeline
    • 5.1.1.3. Increasing prevalence of cardiovascular diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Presence of alternative methods
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing funding for R&D of surgical procedures
    • 5.1.3.2. Inclination towards drug-eluting devices for angioplasty
  • 5.1.4. Challenges
    • 5.1.4.1. Product recall
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Resorbable Vascular Scaffold Market, by Material Type

• 6.1. Introduction
• 6.2. Metal Based BVS
• 6.3. Polymer Based BVS

7. Resorbable Vascular Scaffold Market, by Application

• 7.1. Introduction
• 7.2. Coronary Artery Stents
• 7.3. Peripheral Artery Stents

8. Resorbable Vascular Scaffold Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Cardiac Centers
• 8.4. Hospitals

9. Americas Resorbable Vascular Scaffold Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Resorbable Vascular Scaffold Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Resorbable Vascular Scaffold Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. B. Braun Medical Inc.
• 3. Biotronik SE & Co. KG
• 4. Cardionovum GmbH
• 5. Elixir Medical Corporation
• 6. Kyoto Medical Planning Co., Ltd.
• 7. Lepu Medical Technology(Beijing)Co.,Ltd.
• 8. Medtronic PLC
• 9. Meril Life Sciences Pvt. Ltd.
• 10. MicroPort Scientific Corporation
• 11. OrbusNeich Medical Company Limited
• 12. Reva Medical, Inc.
• 13. Terumo Corporation
• 14. Translumina
• 15. Wego Healthcare (Shenzhen) Co., Ltd.